Biomics Biotechnologies, China, founded in February 2006, is on road to be counted as one of Asia's leading RNA interference (RNAi) therapeutical technology company. The company has a portfolio of more than 40 patents and patent applications... Read more
The present chairman of Singapore's Biomedical Research Council (BMRC) Prof Sir George Radda has changed the way universities... Read more
Driven by the demand for affordable and simple diagnostics, VolitionRx has been focusing on diagnostic tests for cancer that... Read more
Neisseria meningitidis (meningococcus) is a cause of the contagious bacterial meningitis that can lead to life-threatening infections in... Read more
Development of stem cell therapies requires innovative technologies and processes to overcome safety concerns and VeriStem Technologies... Read more
With the need for green fuel technologies growing bigger every day, New Zealand company LanzaTech is providing an alternative solution to... Read more
Steering Bionomics' focus towards large markets where there is a defined clinical need for new treatments, Dr Rathjen helped it gain global... Read more
Diabetes has emerged as a major concern in Asia Pacific and companies are making a beeline to develop treatments for it. ASX-listed GI Dynamics... Read more
Prof Mark Kendall, a scientist at the Australian Institute of Bioengineering and Nanotechnology under University of Queensland, came up... Read more
Chinese vaccine development companies are raising the bar to meet international standards. However, access to foreign markets remains a... Read more
A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundation (CARIF), a non-profit... Read more
Novo Informatics is the brainchild of a group of students and researchers from the Indian Institute of Technology (IIT), Delhi, a premier... Read more
Survey Box